BioMS Medical Announces Q3 Results and Continues Pivotal Multiple Sclerosis T...

BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced financial and operational results for the third quarter ended September 30, 2008. BioMS Medical, in partnership with Eli Lilly and Company (Lilly), is developing...

An Oil Giant's Green Dream

"If you've filled your tank with gas, or warmed your home with natural gas, there's a chance you sent money to Abu-Dhabi. So it might come as a surprise to learn that Abu Dhabi is this week hosting the world's first Future Energy Summit, a three-day gathering of more than...

Pharm Animals Bred to Crank Out Drugs

This is a step beyond the purported 10-wing chickens being grown for KFC... Pharming raises all sorts of moral questions, primarily regarding the value of the life of an animal bred versus that of an animal born in the wild: animals experimented on are animals killed, which...

The vaccine to cure every strain of flu

"British scientists are on the verge of producing a revolutionary flu vaccine that works against all major types of the disease. Described as the 'holy grail' of flu vaccines, it would protect against all strains of influenza A - the virus behind both bird flu and the...

Study: Average biotech drug takes $1.2 billion, eight years to develop

BOSTON (AP) - The average drug manufactured by the biotechnology industry costs $1.2 billion and takes a little more than eight years to develop, according to a study released Thursday by the Tufts Center for the Study of Drug Development.

GMO News Roundup

"The saying used to be what's Good For GM is Good for America. Today it's what's good for GMO is good for American corporate agribusiness, and bad for the rest of us."